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Abstract
The intricacy of childbirth is something that is both beautiful, yet 
potentially devastating if not approached appropriately for each 
individual mother and fetus. Maternal hemorrhaging is one, of the many, 
adverse outcomes that can present with childbirth. The potential risks of 
childbirth have led to various techniques and modes of delivery to reduce 
the possible detriments, posing debates over which is the “right” 
protocol. Due to the variability in research findings regarding postpartum 
hemorrhaging (PPH) and maternal and fetal safety, this research poses 
the question of: in multiparous women who have previously delivered via 
cesarean section [P], does vaginal birth after cesarean (VBAC) [I] reduce 
the need for maternal transfusion due to blood loss [O] when compared 
to elective repeat cesarean delivery (ERCD) [C]?
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PPH has been defined as blood loss greater than the anticipated amount 
of 500cc in vaginal birth and 1000cc in cesarean delivery. PPH does not 
discriminate against race, socioeconomic settings, nor maternal age. It is 
reported that 3-5% of obstetric patients experience PPH resulting in 12% 
of maternal deaths in the United States, and that those with blood loss of 
1500mL or more require massive transfusions. Both VBAC and ERCD 
rank maternal hemorrhaging as one of the most detrimental associated 
outcomes. While previous vaginal deliveries and indications of 
nonrecurring CD, such as breech, are favorable in trial of labor after 
cesarean (TOLAC), increased maternal age, maternal BMI, and 
preexisting medical diseases are unfavorable factors. Due to inconclusive 
findings on this topic thus far, this research hopes to weigh the potential 
detriments to both procedures, ultimately determining the safer option for 
both mother and fetus.
Introduction
Methods
A literature search was conducted in October 2019, using Health 
Source: Nursing/Academic Edition, PubMed, and Google Scholar. 
Fifteen articles, written on retrospective and cross-sectional 
studies, were included within this research based on their date of 
publication (2009-2019), method of delivery utilized, and 
transfusion guidelines followed. In addition to these guidelines, 
systematic reviews and meta-analyses were excluded. Search 
terms, such as “post-partum hemorrhage AND VBAC OR ERCD” 
and “bleeding OR hemorrhage AND vaginal birth after cesarean 
OR elective repeat cesarean delivery” were used. Studies were 
only included if human subjects were utilized. 
3/6 studies recommended VBAC and/or TOLAC, while no studies 
suggested ERCD as the preferable delivery option. All three of those 
studies required transfusion, while five studies that utilized ERCD 
required transfusions, as well. 3/6 studies compared VBAC directly to 
ERCD, while the remaining three focused solely on VBAC or ERCD. 
Peri vs postpartum hemorrhage was not always differentiated. 
Not all studies shared the same parameters for necessitating  transfusion, 
as some studies described PPH as “excessive blood loss”, a subjective 
term that could vary amongst those measuring. Despite such 
discrepancies, one universal conclusion made amongst studies was that a 
communicative relationship between patient and provider is necessary to 
implement within treatment. 
DiscussionResults
Vaginal Birth After Cesarean (VBAC) Compared to Elective Repeat 
Cesarean Delivery (ERCD) in Maternal Hemorrhage Prevention
Due to the individualized nature of childbirth, the most agreed upon 
conclusion of this research has been that obstetrics and women’s 
health is an incredibly individualized field of medicine, one that 
requires a mutual relationship and understanding between patient 
and practitioner. 
Risk factors that women present with ultimately influence the 
decision of undergoing VBAC or ERCD. 
With this understanding in mind, the current research tends to be 
in support of TOLAC and VBAC, given the mother has no 
contraindications to either. Such risk factors include, but are not 
limited to, an incision into the myometrium for TOLAC and major 
placenta previa for VBAC. More studies showed that ERCDs 
resulted in a higher need for maternal transfusion.
Conclusion
Though conclusive evidence was not found, and no 
definitive medical advice can be implemented for every 
patient, the research suggests that TOLAC and VBAC 
are encouraged if the woman does not have any health 
complications or risk factors that would contraindicate 
this mode of delivery. More maternal blood transfusions 





























Ahmadzia et al 
(2018) N/A S N/A NS NS
Cahill et al (2006)
S S S N/A N/A
Larsson et al (2010)
S S N/A N/A N/A
Mengesha et al 
(2019) N/A S S N/A NS
Nisenblat et al (2006)
N/A S S N/A NS
Oboro et al (2010)  
S N/A S NS N/A
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Table 1. Comparison of Results
Cesarean Delivery Vaginal Delivery
